The effects of SGLT-2 inhibitors vs renin-angiotensin-aldosterone system inhibition on cardiovascular outcomes of heart failure with preserved ejection fraction: network meta-analysis
Empagliflozin improves cardiovascular and renal outcomes in patients with preserved ejection fraction irrespective of age: insights from the EMPEROR-Preserved trial
Combination treatment by epoxyeicosatrienoic acid analog and angiotensin-convertase enzyme inhibitor in congestive heart failure: a preclinical study on animal model
Long-term prognostic implications of in-hospital changes in N-terminal pro-B-type natriuretic peptide levels among hospitalized patients with atrial fibrillation with or without heart failure